Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Russian Federation,United States,France,Canada,Sweden,Spain,Lithuania,Czech Republic,Austria,Australia
nct
Update Il y a 5 ans
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
To evaluate the safety and tolerability of atacicept and to explore if atacicept reduces central nervous system inflammation in subjects with relapsing multiple sclerosis (RMS) as assessed by frequent magnetic resonance imaging (MRI). This study is randomised. Study medication is administered via subcutaneous (under the skin) injections.
Country
Australia
,
Austria
,
Belgium
,
Canada
,
Czech Republic
,
France
,
Germany
,
Lebanon
,
Lithuania
,
Netherlands
,
Russian Federation
,
Spain
,
Sweden
,
Switzerland
,
Ukraine
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1